ArticleLung cancer management2026

At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study.

Lily Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.